The Johnson & Johnson Sisonke vaccination programme will resume this Wednesday.
The rollout was put on hold after cases of rare blood clots were reported in six recipients in the US.
But the South African Health Products Regulatory Authority found no evidence of blood clots in this country.
Health authorities say there is a one in a million chance of getting clotting disorders.
Phase one of the vaccination programme, aimed at health workers, is expected to end on 16 May.
Those taking part will be required to give consent again.
Authorities have recommended that pregnant and lactating women be excluded.
More Stories
Thabo Bester Did Not Die In A Fire But Escaped From Prison – DCS
SA Won’t Go Beyond Stage 6 Power Cuts – Ramokgopa
World TB Day – Yes! We Can End TB
Medical Fees Rise By 5.3% In February – Stats SA
Power Cuts Case Continues
Ramokgopa Tours Troubled Tutuka
EFF’s No-Confidence Motion Against Speaker Fails
The National Treasury Should Do More To Alleviate Household Costs Of Loadshedding
Eskom Concedes That Outrage Over Power Cuts Warranted
Electricity Minister To Visit All Power Stations
Over 500 Arrested Nationwide During Protest Action
Malema Rubbishes Concerns That EFF Nationwide Protest Will Turn Violent